Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01694784 · ClinicalTrials.gov registry record · NA

Understanding and Discouraging Overuse of Potentially Harmful Screening Tests

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
775
Enrollment target

NCT01694784: Completed NA study, sponsored by University of North Carolina, Chapel Hill.

NCT01694784 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 775 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01694784, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
775 participants
Enrollment target

Study Summary

Most prevention efforts focus on promoting services (e.g. vaccination, screening tests). While some of these services have clear net benefit, many instead have possible or clear net harm. Currently, three quarters of services graded by the U.S. Preventive Services Task Force (USPSTF) have possible or clear net harm (C, I, and D services). Many of these services are delivered in healthcare settings at higher rates than what might be expected based on their potential for harm. This leads to adverse outcomes, excess costs, and missed opportunities to deliver more quality care. An important issue in delivering prevention messages is how to shift toward a focus on the appropriateness of prevention: encouraging services with clear net benefit and either discouraging or reducing demand for services with possible or clear net harm. Unfortunately, little is known about what drives overuse of potentially harmful screening services or how to make harms relevant to patients. This randomized controlled trial (RCT) of 775 patients at 4 primary care practices aims to 1) assess factors associated with intent to receive possibly or clearly harmful screening services and 2) determine whether and how patients' plans to get screened change with various presentations of information about harms (e.g. qualitative, quantitative, narrative, framed). The investigators will focus on three types of screening services: osteoporosis screening (previous C recommendation and now no recommendation for women \< 65 years old with no fracture risk factors), prostate-specific antigen (PSA) screening (D recommendation for all men, regardless of age), and colorectal cancer (CRC) screening (C for ages 76-85).

Primary Outcome

Following the example of others, we will measure intent to accept screening services with possible or clear net harm with a single item "I plan to get screened for (name of screening test) in the next year." Because the recommended screening intervals for services under study are variable and not all participants will be due for screening in the next year, we will additionally query participants about plans for screening within the recommended screening interval (e.g. osteoporosis screening--5 y

Interventions

  • BEHAVIORAL Quantitative Information Sheet
  • BEHAVIORAL Qualitative Information Sheet
  • BEHAVIORAL Narrative Information Sheet
  • BEHAVIORAL Framed Information Sheet

Trial Details

FieldValue
Enrollment Target 775 participants
Start Date 2012-09
Est. Completion 2014-06
Phase NA

What the finished NCT01694784 record still lists

NCT01694784 is an interventional study that assigns participants to a tested intervention. The registered 775 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% lower).

The record links to 0 conditions, and to 4 interventions - of which Quantitative Information Sheet is the first listed.

NCT01694784 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01694784 about?

NCT01694784 is a clinical study titled "Understanding and Discouraging Overuse of Potentially Harmful Screening Tests". Most prevention efforts focus on promoting services (e.g. vaccination, screening tests). While some of these services have clear net benefit, many instead have possible or clear net harm. Currently, three quarters of services graded by the U.S. Preventive Services Task Force (USPSTF) have possible o...

What is the current status of trial NCT01694784?

This trial is currently completed. It is a NA study. The enrollment target is 775 participants. The study started on 2012-09. Estimated completion is 2014-06.

What interventions are being tested in trial NCT01694784?

The interventions under investigation include: Quantitative Information Sheet (BEHAVIORAL), Qualitative Information Sheet (BEHAVIORAL), Narrative Information Sheet (BEHAVIORAL), Framed Information Sheet (BEHAVIORAL).

Who is sponsoring clinical trial NCT01694784?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01694784's enrollment target sits among peer trials

775 143rd of 2000 higher than 1,858 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03460769 · 775 participants

    Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)

  • NCT06145763 · 776 participants · NA

    A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial

  • NCT05642611 · 777 participants · Phase 3

    Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

  • NCT06841679 · 778 participants · Phase 2

    Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01694784, the US trial registry maintained by the National Library of Medicine. NCT01694784 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.